View of Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model

Return to Article Details Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model Download Download PDF